GeneDx Holdings Corp vs Warner Music Group Corp — how do they compare? GeneDx Holdings Corp trades at $61.92 (market cap $1.80B), while Warner Music Group Corp trades at $28.2 (market cap $14.64B). The key difference: Warner Music Group Corp is far larger — about 8.1× GeneDx Holdings Corp's market cap, and Warner Music Group Corp pays a 2.71% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| WGS | WMG | |
|---|---|---|
Market Cap | $1.80B | $14.64B |
Sector | Technology | Media |
52-Week High | $167.51 | $34.72 |
52-Week Low | $34.51 | $23.65 |
Enterprise Value | $1.80B | $18.84B |
Dividend Yield | — | 2.71% |
Trailing returns across standard periods
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →